Gender-specific effect of estrogen receptor-1 gene polymorphisms in coronary artery disease and its angiographic severity in Chinese population

Clinica Chimica Acta

Volumn 395, Issue 1-2, 2008, Pages 130-133

  Xu, Haiying ^a   Hou, Xuwei ^a   Wang, Ningfu ^a   Hui, Bo ^b   Jin, Jianfen ^a   Yun, Shen ^a   Wang, Xiaoyan ^a   He, Xiuying ^a   He, Jianjun ^c   Zhang, Sheng ^c   Han, Yunfeng ^d  

^a HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

^c Baodiao Hospital   (China)

^d QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

Chinese; Coronary artery disease; Estrogen receptor 1; Gene polymorphisms

Indexed keywords

DNA; ESTROGEN RECEPTOR; LOW DENSITY LIPOPROTEIN; RESTRICTION ENDONUCLEASE;

ADULT; ANGIOGRAPHY; ARTICLE; BLOOD VESSEL DIAMETER; CHINA; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA CLEAVAGE; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; PVUII GENOTYPE; SEX DIFFERENCE; XBAI GENOTYPE;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DNA; ESTROGEN RECEPTOR ALPHA; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 47649129762     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.06.004     Document Type: Article

References (35)

1. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340 (1999) 1801-1811
2. Godsland I.F. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 75 (2001) 898-915
3. Farhat M.Y., Lavigne M.C., and Ramwell P.W. The vascular protective effects of estrogen. FASEB J 10 (1996) 615-624
4. Gruber C.J., Tschugguel W., Schneeberger C., and Huber J.C. Production and actions of estrogens. N Engl J Med 346 (2002) 340-352
5. Colburn P., and Buonassisi V. Estrogen-binding sites in endothelial cell cultures. Science. 201 (1978) 817-819
6. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J., and Scanlan T.S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277 (1997) 1508-1510
7. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., Karas R.H., Mendelsohn M.E., and Shaul P.W. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103 (1999) 401-406
8. Hodgin J.B., Krege J.H., Reddick R.L., Korach K.S., Smithies O., and Maeda N. Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice. J Clin Invest 107 (2001) 333-340
9. Evangelopoulos D., Alevizaki M., Lekakis J., et al. Molecular analysis of the estrogen receptor alpha gene in men with coronary artery disease: association with disease status. Clin Chim Acta 331 (2003) 37-44
10. Lehtimäki T., Kunnas T.A., Mattila K.M., et al. Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study. J Mol Med. 80 (2002) 176-180
11. Kunnas T.A., Lehtimäki T., Karhunen P.J., et al. Estrogen receptor genotype modulates myocardial perfusion in young men. J Mol Med 82 (2004) 821-825
12. Shearman A.M., Cupples L.A., Demissie S., et al. Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 290 (2003) 2263-2270
13. S.C. Schuit, H.H. Oei, J.C. Witteman, et al. Estrogen receptor gene polymorphisms and risk of myocardial infarction. JAMA 291:2969-2977.
14. Kunnas T.A., Laippala P., Penttilä A., Lehtimäki T., and Karhunen P.J. Association of polymorphism of human alpha oestrogen receptor gene with coronary artery disease in men: a necropsy study. BMJ 29 321 (2000) 273-274
15. Pollak A., Rokach A., Blumenfeld A., et al. Association of oestrogen receptor alpha gene polymorphism with the angiographic extent of coronary artery disease. Eur Heart J 25 (2004) 240-245
16. Matsubara Y., Murata M., Kawano K., et al. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol 17 (1997) 3006-3012
17. Almeida S., Franken N., Zandoná M.R., et al. Estrogen receptor 2 and progesterone receptor gene polymorphisms and lipid levels in women with different hormonal status. Pharmacogenomics J 5 (2005) 30-34
18. Almeida S., and Hutz M.H. Genetic variation of estrogen metabolism and the risks of cardiovascular disease. Curr Opin Investig Drugs. 8 10 (2007 Oct) 814-820
19. Lussana F., Faioni E.M., Mavilia C., et al. Association of estrogen receptor-alpha genepolymorphisms with venous thrombosis. Haematologica 91 (2006) 279-280
20. Kjaergaard A.D., Ellervik C., Tybjaerg-Hansen A., et al. Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis. Circulation 115 (2007) 861-871
21. Rokach A., Pollak A., Rosen L., et al. Estrogen receptor gene polymorphisms are associated with the angiographic extent of coronary artery disease. J Clin Endocrinol Metab 90 (2005) 6556-6560
22. Evangelopoulosa D., Alevizakib M., Lekakisb J., et al. Molecular analysis of the estrogen receptor alpha gene in men with coronary artery disease: association with disease status. Clin Chim Acta 331 (2003) 37-44
23. Cerillo G., Rees A., Manchanda N., Reilly C., Brogan I., White A., and Needham M. The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner. J Steroid Biochem Mol Biol 67 (1998) 79-88
24. Srivastava S., Weitzmann M.N., Cenci S., Ross F.P., Adler S., and Pacifici R. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest. 104 (1999) 503-513
25. Petrovic D., and Peterlin B. Estrogen receptor dinucleotide (TA) polymorphism does not predict premature myocardial infarction in Caucasian women. Cardiol 99 (2003) 163-165
26. Ferrero V., Ribichini F., Matullo G., et al. Estrogen receptor-alpha polymorphisms and angiographic outcome after coronary artery stenting. Arterioscler Thromb Vasc Biol. 23 (2003) 2223-2228
27. Hayashi K., Maeda S., Iemitsu M., et al. Sex differences in the relationship between estrogen receptor alpha gene polymorphisms and arterial stiffness in older humans. Am J Hyperten 20 (2007) 650-656
28. Ellis J.A., Infantino T., and Harrap S.B. Sex-dependent association of blood pressure with oestrogen receptor genes ERalpha and ERbeta. J Hyperten 22 (2004) 1127-1131
29. Almeida S., and Hutz M.H. Estrogen receptor 1 genepolymorphisms and coronary artery disease in the Brazilian population. Braz J Med Biol Res 39 (2006) 447-454
30. Mansur Ade P., Nogueira C.C., Strunz C.M., Aldrighi J.M., and Ramires J.A. Genetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Arch Med Res. 36 (2005) 511-517
31. Alevizaki M., Saltiki K., Cimponeriu A., et al. Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor alpha polymorphic variants. Eur J Endocrinol. 156 (2007) 489-496
32. Koivu T.A., Fan Y.M., Mattila K.M., et al. The effect of hormone replacement therapy on atherosclerotic severity in relation to ESR1 genotype in postmenopausal women. Maturitas 44 (2003) 29-38
33. Herrington D.M., Howard T.D., Brosnihan K.B., McDonnell D.P., Li X., Hawkins G.A., Reboussin D.M., Xu J., Zheng S.L., Meyers D.A., and Bleecker E.R. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105 (2002) 1879-1882
34. Lehtimäki T., Laaksonen R., Mattila K.M., et al. Oestrogen receptor gene variation is a determinant of coronary reactivity in healthy young men. Eur J Clin Invest. 32 (2002) 400-404
35. Huang Q., Wang T.H., Lu W.S., Mu P.W., Yang Y.F., Liang W.W., Li C.X., and Lin G.P. Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou. Chin Med J (Engl) 119 (2006) 1794-1801